AJIC: American Journal of Infection Control
Volume 37, Issue 8 , Pages 626-630 , October 2009

A fall in bloodstream infections followed a change to 2% chlorhexidine in 70% isopropanol for catheter connection antisepsis: A pediatric single center before/after study on a hemopoietic stem cell transplant ward

References 

  1. Rosenthal VD, Maki DG, Salomao R, Álvarez-Moreno C, Mehta Y, Higuera F, et al. International Nosocomial Infection Control Consortium Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med. 2006;145:582–589
  2. Arnow PM, Quimosing EM, Beach M. Consequences of intravascular catheter sepsis. Clin Infect Dis. 1993;16:778–784
  3. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med. 2000;132:391–402
  4. Sitges-Serra A, Puig P, Linares J, Perez JL, Farrero N, Jaurrieta E, et al. Hub colonization as the initial step in an outbreak of catheter-related sepsis due to coagulase negative staphylococci during parenteral nutrition. J Parenter Enteral Nutr. 1984;8:668–672
  5. McDonald LC, Banerjee SN, Jarvis WR. Line-associated bloodstream infections in pediatric intensive-care-unit patients associated with a needle less device and intermittent intravenous therapy. Infect Control Hosp Epidemiol. 1998;19:772–777
  6. Rupp ME, Sholtz LA, Jourdan DR, Marion ND, Tyner LK, Fey PD. Outbreak of bloodstream infection temporally associated with the use of an intravascular needleless valve. Clin Infect Dis. 2007;44:1408–1414
  7. Salzman MB, Isenberg HD, Rubin LG. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. J Clin Microbiol. 1993;31:475–479
  8. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep. 2002;51(RR-10):1–29
  9. Pratt RJ, Pellowe CM, Wilson JA, Loveday H, Harper P, Jones S, et al. Epic 2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect. 2007;65(Suppl 1):S1–64
  10. Casey AL, Worthington T, Lambert PA, Quinn D, Faroqui MH, Elliott TSJ. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow connector. J Hosp Infect. 2003;54:288–293
  11. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338:339–343
  12. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis. 1993;168:400–407
  13. Segura M, Alvarez-Lerma F, Tellado JM, Jimenez-Ferreres J, Oms L, Rello J, et al. A clinical trial on the prevention of catheter-related sepsis using a new hub model. Ann Surg. 1996;223:363–369
  14. Menyhay SZ, Maki DG. Disinfection of needleless catheter connectors and access ports with alcohol may not prevent microbial entry: the promise of a novel antiseptic-barrier cap. Infect Control Hosp Epidemiol. 2006;27:23–27
  15. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2007;355:2725–2732
  16. Pronovost P. Interventions to decrease catheter-related bloodstream infections in the ICU: the Keystone Intensive Care Unit Project. Am J Infect Control. 2008;36:S171;e1-5

 Conflicts of interest: None to report.

PII: S0196-6553(09)00596-3

doi: 10.1016/j.ajic.2009.03.014

AJIC: American Journal of Infection Control
Volume 37, Issue 8 , Pages 626-630 , October 2009

Article Tools

* Image Usage & Resolution